Key therapeutic topics were updated in 2018 to support medicines optimisation. These include:
It is important to ensure:
NSAID prescribing is reviewed regularly to ensure it is appropriate, especially in older people and those who are at higher risk of gastrointestinal, renal and cardiovascular morbidity and mortality
The prescriber uses the lowest effective dose and shortest duration of treatment to control the symptoms. Ibuprofen (1,200mg a day or less) or naproxen (1,000mg a day
or less) should be used
A proton pump inhibitor (PPI) is prescribed with the NSAIDs for people who have osteoarthritis or rheumatoid arthritis.
Type 2 diabetes
Guidelines for adults have been updated and now recommend:
Adopting an individualised approach to diabetes care assessing benefits and risks
Involving people with type 2 diabetes in decisions, including their HbA1c target
Reassessing individual needs and medicines at reviews, optimising prescribing in line with clinical circumstances, preferences and needs, as well as cost, by choosing medicines with the lowest acquisition cost if two in the same class are appropriate
Not routinely offering self-monitoring of blood glucose levels for adults.